Dose intensity in advanced ovarian cancer: have we answered the question?
Fennelly
D
D
Breast and Gynecological Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D016190:Carboplatin; D002945:Cisplatin